Guided Therapeutics (Guided Therapeutics) Days Sales Outstanding : 19.96 (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Guided Therapeutics Days Sales Outstanding?

Guided Therapeutics's average Accounts Receivable for the three months ended in Dec. 2023 was $0.01 Mil. Guided Therapeutics's Revenue for the three months ended in Dec. 2023 was $0.03 Mil. Hence, Guided Therapeutics's Days Sales Outstanding for the three months ended in Dec. 2023 was 19.96.

The historical rank and industry rank for Guided Therapeutics's Days Sales Outstanding or its related term are showing as below:

GTHP' s Days Sales Outstanding Range Over the Past 10 Years
Min: 4.49 Med: 109.54 Max: 730
Current: 25.33

During the past 13 years, Guided Therapeutics's highest Days Sales Outstanding was 730.00. The lowest was 4.49. And the median was 109.54.

GTHP's Days Sales Outstanding is ranked better than
92.7% of 808 companies
in the Medical Devices & Instruments industry
Industry Median: 64.065 vs GTHP: 25.33

Guided Therapeutics's Days Sales Outstanding increased from Dec. 2022 (0.00) to Dec. 2023 (19.96).

Guided Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Guided Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guided Therapeutics Days Sales Outstanding Chart

Guided Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

131.81

66.20

157.72

730.00

24.21

Guided Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															-	26.96	14.52	-	19.96

Competitive Comparison of Guided Therapeutics's Days Sales Outstanding

For the Medical Devices subindustry, Guided Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guided Therapeutics's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Guided Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Guided Therapeutics's Days Sales Outstanding falls into.

Guided Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Guided Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.006	+	0.007)	/	2 )	/	0.098	*	365
=	0.0065					/	0.098	*	365
=	24.21

Guided Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.007	+	0.007)	/	2 )	/	0.032	*	365 / 4
=	0.007					/	0.032	*	365 / 4
=	19.96

Guided Therapeutics (OTCPK:GTHP) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Guided Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Guided Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Guided Therapeutics (Guided Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guided Therapeutics Inc (OTCPK:GTHP) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

5835 Peachtree Corners East, Suite B, Norcross, GA, USA, 30092

Website

https://www.guidedinc.com

Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.

Executives

John E Imhoff	director, 10 percent owner	P.O. BOX 31083, SEA ISLAND GA 31561
Alan Grujic	director	349 FORBES AVE, SAN RAFAEL CA 94901
Michael C James	director	2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Richard P. Blumberg	director	2357 HOBART AVENUE S.W., SEATTLE WA 98116
Lynne H Imhoff	10 percent owner	2716 SOUTH ROCKFORD ROAD, TULSA OK 74114
Gene S Cartwright	officer: Chief Executive Officer	4088 COMMERCIAL AVE, NORTHBROOK IL 60062
Parsons & Whittemore Enterprises Corp.	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
George F. Landegger 2010 10-year Grat	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
George F Landegger	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK, NEW YORK NY 10573
Whittemore Collection Ltd	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
George F. Landegger 2010 5-year Grat	10 percent owner	4 INTERNATIONAL DRIVE, RYE BROOK NY 10573
Linda Rosenstock	director	5995 PLAZA DRIVE, MAIL STOP CY20-103, CYPRESS CA 90630
Jonathan M Niloff	director	C/O MATRITECH, INC., 330 NEVADA STREET, NEWTON MA 02460
Ronald W Allen	director	P O BOX 1734, ATLANTA GA 30301
Shabbir Bakir Bambot	officer: VP of R & D	4955 AVALON RIDGE PARKWAY, SUITE 300, NORCROSS GA 30071

Guided Therapeutics (Guided Therapeutics) Headlines

From GuruFocus

Dr. Gene Cartwright, CEO of Guided Therapeutics Joins Everett Jolly on Uptick Newswire's “Stock Day” Podcast to Discuss LuViva® Advanced Cervical Scan

By Marketwired Marketwired • 05-16-2018